StoxGud Sign in
60

TTK Healthcare Limited

NSE: TTKHLTCARE · Unclassified

₹915.65+0.03%06 Nov 2026
Check figures: unusual quarterly results in SEP '26 (₹222.97 cr vs a typical ₹12.48 cr). This may be a filing error (e.g. lakh filed as crore) or a genuine one-off; figures are shown as filed. Trailing-twelve-month figures include it.

Ask the data

Instant answers about TTK Healthcare Limited — computed from its filings, no language model
Market cap₹1,294 cr
Current price₹915.65
High / Low₹1,191 / ₹740
P/E4.7
P/B0.96
Book value₹952.9
ROE20.5%
ROCE25.0%
Debt / equity0.02
Dividend yield1.09%
EPS (TTM)₹195.71
Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
showing latest 6 of 7 periods
FY20FY21FY22FY23FY24FY25FY26
Revenue645.8636.5599.2725.1752.8801.5857.3
EBITDA28.334.921.831.437.334.826.2
Operating margin4.4%5.5%3.6%4.3%5.0%4.3%3.1%
Interest3.32.23.25.22.83.32.9
Depreciation14.413.712.612.813.18.38.8
Profit before tax19.437.024.861.684.1108.382.6
Tax7.1-9.46.317.021.326.716.9
Net profit12.346.441.6639.762.881.765.7
EPS ₹8.7232.8729.43452.7244.4757.7946.48
Operating cash flow——45.0-26.1-4.9-4.0-21.1
Capex——6.511.710.412.85.8
Dividend paid——8.514.114.114.114.1
Total assets———1,170.11,200.61,281.21,328.7
Equity———953.41,000.91,065.01,114.8

Quarterly performance

last 32 quarters · ₹ crore
showing latest 8 of 32 periods
JUN '18SEP '18DEC '18JUN '19SEP '19DEC '19MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '21DEC '21MAR '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
Revenue173.1166.1149.1178.6164.8165.8136.5116.4159.7179.2181.3170.8206.4212.5158.7169.8182.6180.1202.1185.8183.8181.1207.9198.5204.7190.4226.4203.6209.3218.0257.6233.4
Operating profit15.813.510.48.48.48.72.7-0.79.111.814.78.815.817.14.74.08.415.210.09.55.312.46.98.27.712.02.75.37.111.014.73.8
Operating margin9.1%8.1%7.0%4.7%5.1%5.2%2.0%-0.6%5.7%6.6%8.1%5.2%7.6%8.1%2.9%2.3%4.6%8.4%5.0%5.1%2.9%6.9%3.3%4.1%3.8%6.3%1.2%2.6%3.4%5.1%5.7%1.6%
Other income1.81.91.71.91.92.22.71.92.12.53.43.73.04.55.211.111.815.614.616.015.916.117.017.717.818.717.919.017.417.816.818.7
Interest1.10.90.70.70.80.90.90.60.60.30.70.60.61.51.00.80.80.90.90.70.20.90.90.70.80.90.80.80.70.60.50.6
Depreciation3.63.53.53.53.63.73.63.53.43.43.43.43.33.33.13.33.23.13.23.33.33.32.02.02.12.22.22.22.22.12.12.2
Profit before tax12.911.08.06.16.06.40.9-2.915.310.614.18.517.516.85.810.916.226.820.621.617.724.240.823.222.621.817.621.314.129.528.9267.9
Tax5.14.33.12.52.31.90.5-0.5-15.52.93.72.54.74.61.63.04.26.35.05.54.86.09.26.05.95.64.70.93.57.87.645.0
Net profit0.00.00.03.63.84.50.4-2.430.87.710.36.012.812.210.69.912.016.915.716.012.918.331.617.216.716.113.020.410.521.821.3223.0
EPS ₹11.164.713.462.582.683.170.30-1.7021.805.447.324.249.078.617.527.028.4911.9911.0911.339.1312.9322.3512.1711.8411.439.2014.437.4515.4015.06157.80
Revenue YoY———3.2%-0.8%11.2%—-34.8%-3.1%8.1%32.8%46.7%29.2%18.6%-12.5%-17.7%-14.1%13.5%—9.4%0.7%0.5%2.9%6.8%11.4%5.1%8.9%2.6%2.2%14.5%13.7%14.6%
Profit YoY———————-165.9%715.1%71.7%2364.3%—-58.4%58.1%2.6%-22.6%-1.3%59.5%—61.6%7.4%7.9%101.5%7.4%29.8%-11.6%-58.8%18.5%-37.1%34.7%63.7%993.5%

Earlier results (standalone, Sep '07 – Mar '18)

₹ crore · from BSE, before the NSE XBRL filings begin

TTK Healthcare Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 10 periods
FY09†FY10†FY11†FY12†FY13†FY14†FY15†FY16†FY17†FY18†
Revenue220.5252.6311.0353.8382.3416.2482.9518.9532.9559.3
Operating profit12.815.721.523.820.219.729.640.539.346.2
Operating margin5.8%6.2%6.9%6.7%5.3%4.7%6.1%7.8%7.4%8.3%
Other income4.03.44.34.76.76.16.65.65.76.5
Interest1.91.81.72.62.53.03.63.33.13.8
Depreciation1.81.82.02.42.73.26.17.211.913.3
Profit before tax13.215.522.123.621.619.726.335.530.135.6
Tax5.36.47.47.97.47.310.212.910.712.0
Net profit7.99.114.715.614.212.416.222.719.323.6

Quarters

showing latest 8 of 43 periods
SEP '07†DEC '07†MAR '08†JUN '08†SEP '08†DEC '08†MAR '09†JUN '09†SEP '09†DEC '09†MAR '10†JUN '10†SEP '10†DEC '10†MAR '11†JUN '11†SEP '11†DEC '11†MAR '12†JUN '12†SEP '12†DEC '12†MAR '13†JUN '13†SEP '13†DEC '13†MAR '14†JUN '14†SEP '14†DEC '14†MAR '15†JUN '15†SEP '15†DEC '15†MAR '16†JUN '16†SEP '16†DEC '16†MAR '17†JUN '17†SEP '17†DEC '17†MAR '18†
Revenue48.447.244.356.453.856.254.166.764.263.158.678.875.979.876.592.586.586.788.1108.595.692.285.9109.1100.7105.8100.6129.8120.4120.8111.9138.7129.8130.8119.6153.2136.4123.7119.6125.4142.8146.0145.1
Operating profit3.52.61.11.14.14.82.93.93.53.54.76.04.36.25.16.95.26.35.47.26.13.63.23.25.65.75.26.36.57.79.08.68.712.510.611.810.17.69.9-2.013.219.115.9
Operating margin7.2%5.6%2.6%1.9%7.5%8.6%5.4%5.9%5.4%5.6%8.0%7.6%5.6%7.8%6.6%7.4%6.1%7.3%6.1%6.6%6.4%4.0%3.7%2.9%5.6%5.4%5.2%4.9%5.4%6.3%8.1%6.2%6.7%9.6%8.9%7.7%7.4%6.1%8.3%-1.6%9.2%13.1%11.0%
Other income0.50.61.60.80.70.91.60.80.70.71.20.61.70.81.20.91.11.11.51.21.32.32.01.51.51.31.91.41.61.52.01.31.41.21.61.31.01.71.71.21.21.82.3
Interest0.50.50.50.50.50.50.40.60.50.40.20.40.40.50.40.50.60.60.80.60.70.60.60.70.80.70.81.00.80.91.00.80.70.71.11.00.80.70.60.70.71.41.0
Depreciation0.50.40.40.50.40.40.50.50.50.50.50.50.50.50.60.60.60.60.60.60.70.70.70.70.80.80.91.11.21.32.51.61.51.52.62.93.03.02.93.03.03.83.6
Profit before tax2.92.21.80.93.84.73.73.73.23.45.25.85.16.05.36.85.26.15.57.26.04.63.83.25.65.55.45.76.26.97.67.67.811.68.49.17.35.68.1-4.510.715.713.7
Tax2.71.0-9.00.41.51.81.61.31.31.42.32.11.42.11.92.41.82.01.72.42.01.51.51.21.92.02.12.02.42.73.02.93.14.32.53.52.72.02.50.02.93.55.7
Net profit0.11.210.80.52.33.02.12.31.92.02.93.73.73.93.44.43.44.13.74.94.03.12.22.03.63.53.23.63.84.24.64.74.77.35.95.64.63.65.6-4.57.912.28.0
EPS ₹0.191.5213.250.652.823.652.592.942.452.603.694.754.795.034.385.644.405.304.786.255.203.942.892.614.664.504.194.664.875.405.886.076.089.397.657.225.884.617.19-5.7610.1215.775.66
Revenue YoY————11.1%19.1%22.0%18.2%19.3%12.3%8.4%18.2%18.3%26.5%30.4%17.4%13.9%8.6%15.2%17.3%10.6%6.4%-2.5%0.6%5.3%14.7%17.1%18.9%19.6%14.2%11.3%6.9%7.8%8.2%6.9%10.5%5.1%-5.4%-0.0%-18.1%4.7%18.0%21.4%
Profit YoY————1420.0%140.7%-80.5%339.6%-16.2%-31.8%36.7%58.4%94.8%93.6%18.5%18.7%-8.1%5.4%9.1%11.0%18.1%-25.7%-39.4%-58.2%-10.6%14.1%44.4%78.3%4.7%20.1%40.6%30.1%24.9%74.0%30.0%18.9%-3.4%-50.9%-6.1%-180.0%72.4%242.2%43.2%

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 23 periods
MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '21DEC '21MAR '22JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
ROE—————————5.7%6.2%6.3%6.3%7.9%7.7%8.1%7.7%5.9%6.1%5.5%5.9%6.6%20.5%
ROCE—————————8.0%8.9%9.0%8.5%10.5%10.2%10.7%10.2%8.1%7.8%7.0%7.5%8.5%25.0%
Net margin1.9%1.1%5.8%6.2%7.3%7.9%5.0%5.4%5.6%7.4%8.1%8.2%8.3%10.4%10.4%10.6%10.2%7.7%8.0%7.2%7.7%8.3%30.1%
EBITDA margin4.4%3.3%3.4%3.9%5.5%6.4%6.9%7.3%6.2%5.1%5.8%5.3%5.0%4.5%4.3%4.4%4.3%3.7%3.4%3.3%3.1%4.3%4.0%
Debt / equity—————————0.030.020.020.020.020.030.030.020.020.020.020.020.020.02
Interest coverage6.944.247.4510.6117.6922.8324.1418.0714.3423.0026.6632.2931.5938.9239.3734.0733.6327.3726.0224.4529.1835.86140.52
Asset turnover—————————0.630.630.640.630.630.610.630.630.640.640.640.650.670.56

Balance sheet

equity vs borrowings over time · ₹ crore
showing latest 6 of 9 periods
SEP '22MAR '23SEP '23MAR '24SEP '24MAR '25SEP '25MAR '26SEP '26
Share capital14.114.114.114.114.114.114.114.114.1
Other equity / reserves914.2939.2958.2986.81,024.61,050.91,071.01,100.71,332.4
Total equity928.4953.4972.41,000.91,038.81,065.01,085.11,114.81,346.5
Borrowings23.625.523.421.530.124.226.323.926.0
Current liabilities299.6210.8204.7195.8224.2210.9205.3206.2297.1
Non-current liabilities9.96.05.23.93.65.25.27.77.6
Total assets1,237.91,170.11,182.31,200.61,266.61,281.21,295.51,328.71,651.2
Property, plant & equipment75.171.276.674.874.080.978.472.761.3
Capital work-in-progress0.62.81.60.85.30.10.51.45.0
Investments225.912.814.412.616.311.212.08.712.0
Inventories76.084.589.597.0105.3108.6102.1108.7112.9
Receivables77.092.192.386.495.890.5111.5110.7117.0
Cash & equivalents153.89.37.711.09.59.012.721.989.8

Cash flow

annual · ₹ crore · line = free cash flow
FY22FY23FY24FY25FY26
Cash from operations45.0-26.1-4.9-4.0-21.1
Cash from investing-30.633.028.520.151.6
Cash from financing-9.1-12.4-21.9-18.1-17.6
Capex6.511.710.412.85.8
Free cash flow38.5-37.8-15.3-16.8-26.9
Dividends paid8.514.114.114.114.1

Where the assets sit

Sep '26 · ₹ crore
Fixed assets (PPE)
₹61.3 cr4%
CWIP
₹5.0 cr0%
Investments
₹12.0 cr1%
Inventories
₹112.9 cr7%
Receivables
₹117.0 cr7%
Cash & equivalents
₹89.8 cr5%
Other assets
₹1,253.2 cr76%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
TTK Healthcare Limited1,294915.654.70.9620.5%

StoxGud checklist: Neutral setup · 6/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-12.5%
6 months-2.1%
1 year-22.0%
3Y CAGR-10.1%
5Y CAGR+6.1%
10Y CAGR-0.5%
50-day avg₹1,038.28
200-day avg₹960.68
RSI (14)34

FAQs

What is the share price of TTK Healthcare Limited?

TTK Healthcare Limited (TTKHLTCARE) closed at ₹915.65 on NSE on 06 Nov 2026.

What is the market cap of TTK Healthcare Limited?

₹1,294 crore at the latest close.

What is the P/E ratio of TTK Healthcare Limited?

4.7, on trailing-twelve-month earnings from its filings.

How fast is TTK Healthcare Limited growing?

TTK Healthcare Limited: revenue has compounded at 5.7% a year over three years; net profit at -53.2% a year. Latest-quarter revenue is up 14.6% year on year, profit up 993.5%.

How profitable is TTK Healthcare Limited?

On a trailing-twelve-month basis return on equity is 20.5%, return on capital employed 25.0%, operating margin 4.0%, net margin 30.1%.

How much debt does TTK Healthcare Limited have?

TTK Healthcare Limited is debt-free: debt to equity is 0.02 with borrowings of ₹26 cr against cash of ₹90 cr (balance sheet of 2026-09-30). Operating profit covers interest 140.5 times.

Financials parsed from TTK Healthcare Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from JUN '18, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.